Internal Medicine, Infectious Disease · Bridgeton, MO
NPI
1134194327
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
12774 Boenker Ln
Bridgeton, MO, 63044
Phone (314) 291-7997
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
1,343 services
Medicare patients, 2024
332
Average age 70
Drug cost, 2024
$725K
492 prescriptions
Company payments, 2025
$371
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adnan Siddiqui was code 99232 (hospital e&m - subsequent), 564 times for 198 patients. In total Adnan Siddiqui billed 1,343 services in 11 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 564 | 198 | $59.99 | $34K |
| 99222 Hospital E&M - Initial | Facility | 288 | 252 | $100.33 | $29K |
| 99233 Hospital E&M - Subsequent | Facility | 276 | 157 | $90.97 | $25K |
| 99231 Hospital E&M - Subsequent | Facility | 165 | 81 | $37.92 | $6,256 |
| 99221 Hospital E&M - Initial | Facility | 21 | 12 | $66.62 | $1,399 |
| 99213 Office E&M - Established | Office | 16 | 11 | $60.30 | $965 |
By year: 2022 $115K for 1,724 services; 2023 $114K for 1,627 services; 2024 $97K for 1,343 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adnan Siddiqui prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 91 prescriptions and refills. In total Adnan Siddiqui wrote 492 Medicare prescriptions that cost $725K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 91 | 91 | Under 11 | $273K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 66 | 72 | Under 11 | $302K |
| Ceftriaxone Ceftriaxone Sodium | 45 | 45 | Under 11 | $1,747 |
| Vancomycin Hcl Generic | 44 | 44 | Under 11 | $6,511 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 26 | 26 | Under 11 | $6,428 |
| Tivicay Dolutegravir Sodium | 24 | 24 | Under 11 | $53K |
| Cefazolin Sodium Generic | 24 | 24 | Under 11 | $1,318 |
| Doxycycline Hyclate Generic | 19 | 23 | Under 11 | $455 |
| Rosuvastatin Calcium Generic | 16 | 36 | Under 11 | $284 |
| Juluca Dolutegravir/Rilpivirine | 13 | 13 | Under 11 | $49K |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 12 | 12 | Under 11 | $1,257 |
| Tenofovir Disoproxil Fumarate Generic | 12 | 12 | Under 11 | $364 |
| Valganciclovir Hcl Generic | 12 | 12 | Under 11 | $1,280 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 12 | 12 | Under 11 | $219 |
| Lamivudine Generic | 12 | 12 | Under 11 | $1,828 |
Brand drugs: 198 claims; generic drugs: 294 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adnan Siddiqui $371 ($371 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medical Device Business Services, Inc. with $160.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.